(Q44600058)

English

Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil

scientific article published on 27 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

autoimmune disease

1 reference

based on heuristic

inferred from title

author name string

Irmgard Neumann

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Heinz Fuhrmann

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

I-Fei Fang

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Adelheid Jaeger

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Peter Bayer

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Josef Kovarik

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

27 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3514-3520

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mycophenolate mofetil: how to further improve using an already successful drug?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Therapeutic drug monitoring of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Therapeutic drug monitoring of mycophenolate mofetil in transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Mycophenolate mofetil and systemic lupus erythematosus: an overview.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Is mycophenolate mofetil a safe and effective treatment for patients with systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Evaluation of the EMIT Mycophenolic Acid Assay from Dade Behring.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Clinical pharmacokinetics of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid After Enteric-Coated Mycophenolate Versus Mycophenolate Mofetil in Patients With Progressive IgA Nephritis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN360

21 January 2018

Identifiers

10.1093/NDT/GFN360

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44600058&oldid=2029114517"